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Abstract: There is an ample epidemiological evidence to support the role of environmental
contaminants such as bisphenol A (BPA) in breast cancer development but the molecular mechanisms
of their action are still not fully understood. Therefore, we sought to analyze the effects of three
common contaminants (BPA; 4-tert-octylphenol, OP; hexabromocyclododecane, HBCD) on mammary
epithelial cell (HME1) and MCF7 breast cancer cell line. We also supplied some data on methoxychlor,
MXC; 4-nonylphenol, NP; and 2-amino-1-methyl-6-phenylimidazo [4–b] pyridine, PhIP. We focused
on testing the prolonged (two months) exposure to low nano-molar concentrations (0.0015–0.0048 nM)
presumed to be oncogenic and found that they induced DNA damage (evidenced by upregulation
of pH2A.X, pCHK1, pCHK2, p-P53) and disrupted the cell cycle. Some agents induced epigenetic
(methylation) changes of tumor suppressor genes TIMP3, CHFR, ESR1, IGSF4, CDH13, and GSTP1.
Obviously, the accumulation of these molecular alterations is an essential base for cancer development.
Consistent with this, we observed that these agents increased cellular invasiveness through collagen.
Cellular abilities to form colonies in soft agar were increased for MCF7. Toxic agents induced
phosphorylation of protein kinase such as EGFR, CREB, STAT6, c-Jun, STAT3, HSP6, HSP27, AMPKα1,
FAK, p53, GSK-3α/β, and P70S6 in HME1. Most of these proteins are involved in potential oncogenic
pathways. Overall, these data clarify the molecular alterations that can be induced by some common
environmental contaminants in mammary epithelial cells which could be a foundation to understand
environmental carcinogenesis.
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1. Introduction
Breast cancer incidence has been generally rising over the last 50 years with rapid increases
observed particularly in developing countries [1–3]. Interestingly, developing countries show a higher
incidence of breast cancer in urban compared to rural areas [4]. Furthermore, studies showed that
women who migrate from low incidence to high incidence environment tend to develop breast cancer
at higher rate than before supporting the hypothesis that breast cancer risk is strongly associated
with environmental factors [5,6]. The Breast Cancer Fund report entitled “State of the Evidence:
The Connection Between Breast Cancer and the Environment” released in October 2010 stresses upon
the growing evidence linking breast cancer to a wide range of environmental exposures including
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bisphenol A (BPA) in food containers. Examples of other exposures include 4-nonylphenol (NP),
4-tert-octylphenol (OP), methoxychlor (MXC), and hexabromocyclododecane (HBCD); all of which
could mimic estrogenic action and hence act as “endocrine disruptors” [7]. Additionally, environmental
exposures include other contaminants of our food and drink such as the common food carcinogen
2-amino-1-methyl-6-phenylimidazo [4–b] pyridine (PhIP) which is a heterocyclic amine formed during
the high-temperature cooking of meat and is known as a “cooked-meat mutagen” [8–10].
BPA is a synthetically produced chemical plasticizer that is commonly used in the production of
polycarbonate plastics and epoxy resins which line various containers for foods, drinks, baby bottles,
and water tanks. Human exposure to BPA occurs mainly through consumption of canned food and
drinks because BPA migrates from the containers into the contents when heated or even under normal
conditions of use. The endocrine disrupting action of BPA can be explained by its weak binding affinity
for the estrogen receptors, ERα and ERβ [11,12]. BPA is also able to induce activation of Erk1/2 in
human breast cancer cells through activation of G protein-coupled receptor 30 (GPR30) [13]. BPA can
induce a complex set of signaling which cannot be explained by its binding to estrogen receptors only
and it exerts many of these effects at low doses even lower than the current “safe” exposure limit for
humans [14–16]. There is a strong evidence to implicate perinatal BPA exposure in mammary cancer
development in various animal models and in vitro [7,15,17,18]. BPA is also able to induce resistance
to doxorubicin, cisplatin, and vinblastine in vitro [19,20].
NP and OP are alkylphenols commonly used in production of laundry and dish detergents,
emulsifiers, and solubilizers, as additives for fuels and lubricants, and are also used in making
fragrances, antioxidants, and fire-retardant materials. Alkylphenols are xenoestrogens that can
exert an endocrine disrupting effect with controversial carcinogenic effect which seems to be lineage
specific [21–23]
MXC is a synthetic organochlorine used as an insecticide that was intended to be a replacement
for DDT. It was banned in the European Union in 2002 and the US by 2003 based on its acute toxicity.
It stimulates the growth of ovarian carcinoma cells in vitro by regulating cell cycle genes and abrogating
apoptosis via an ER-dependent pathway [24]. MXC is detected at higher concentrations in breast cancer
tissues compared to normal tissues [25] but a full understanding of detailed oncogenic mechanism is
still lacking.
HBCD is one of the brominated flame retardants and is a major component of foam that is used
as thermal insulation in the building industry, furniture, automobile interior textiles, car cushions,
and packaging material. HBCD can induce DNA damage [26], exert endocrine disruption, and enhance
growth of cancer cells of various lineages including prostate cancer [27] and ER-positive ovarian
cancer [28]. Furthermore, HBCD induced chemo-resistance to cisplatin in a group of hepatocellular
carcinoma cells (HepG2, MHCC97H, and MHCC97L) [29].
The role of cooked meat toxins such as PhIP in human breast cancer development is suggested by
epidemiological studies and consequently the specific role of PhIP in breast cancer development is
proved and attributed to estrogenic effect in some studies [30,31] but debated by others [32].
Thus, clear evidence of mammary cell oncogenicity together with the detailed oncogenic molecular
pathways are still lacking for some toxic agents. Furthermore, many studies used already established
breast cancer cell lines, which would be difficult to extrapolate on non-malignant (normal, immortalized,
or benign) mammary epithelial cells. Therefore, this project aims to clarify the genotoxic/oncogenic
effects of these toxic chemicals (with a focus on BPA, HBCD, and OP) in mammary epithelial cells and
clarify the molecular pathways of these effects. This study is important to supply evidence-based
approach to cancer prevention.
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2. Results
2.1. Environmental Contaminants and Cell Viability
We first tested different concentrations of toxic agents for their effects on viability. In general,
high concentrations (1–10 µM) reduced viability while exposure to low nanomolar concentrations of
toxic agents (0.0015–0.0048 nM) exerted subtle effect on viability; and some counteracted the cytotoxic
effect of doxorubicin as compared to control (vehicle-exposed) cells. Therefore, we rather focused
on the low concentrations (BPA, MXC, HBCD, NP, OP, PhIP at 0.0043, 0.0028, 0.0015, 0.0045, 0.0048,
0.0044 nM, respectively) because of this potential to exert a pro-survival advantage after treatment with
the cytotoxic agent doxorubicin (Figure 1). The focus of this work was to analyze the transformation
potential on the mammary epithelium which is a long process that naturally might take years, so we
opted for a prolonged exposure (2 months) after which we performed further functional analyses
to dissect the potential long term transformation potentials of these toxic agents particularly on
HME1 cells.
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Figure 1. Representative graph showing altered viability of (A) HME1 and (B) MCF7 treated with
nanomolar concentrations of various toxic agents (BPA, MXC, HBCD, NP, OP, PhIP at 0.0043, 0.0028,
0.0015, 0.0045, 0.0048, 0.0044 nM, respectively) alone or after overnight exposure to a therapeutic
concentration of doxorubicin. Of note that, some toxic agents interfered with the killing effect of
doxorubicin. Mean ± SEM, * p < 0.05, # indicates a tendency (p < 0.10), n = 3 (3 biological × 3 technical).
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2.2. DNA Damage by Environmental Contaminants
DNA damage detection has been optimized and performed using a selection of antibodies against
phosphorylated DNA damage markers (p-Chk1, p-Chk2, p-histone H2A.X, p-p53) by Western blotting
(Figure 2, Table 1). The experiment was performed on the two-month exposed cells to the low
concentration. All 6 agents induced some DNA damage markers. Considering the total number of
upregulated markers as a reflection of overall toxicity, the most DNA damaging agents were BPA and
OP (8 markers each), followed by HBCD and PhIP (7 markers each), then NP (4 markers), and the least
was MXC (3 markers).
Table 1. Induction of DNA damage markers by environmental contaminants.
p-Chk1 p-Chk2 p-HistoneH2A.X p-p53 Total Positive
Markers
HME1 MCF7 HME1 MCF7 HME1 MCF7 HME1 MCF7
BPA ++ ++ ++ ++ ++ ++ ++ ++ 8
MXC - - - + + - - + 3
HBCD + + + ++ ++ - + + 7
NP - ++ - ++ + - - ++ 4
OP + ++ ++ ++ ++ + + + 8
PhIP + ++ ++ ++ ++ - + + 7
Total 9 10 8 10
Footnote: The gray highlight indicates the positive findings included in the “total”. +, weak expression; ++ strong
expression, -, no expression.
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Figure 2. DNA damage response detected in the mammary epithelial cells HME1. Cells were treated 
with toxic agents (bisphenol A (BPA), methoxychlor (MXC), hexabromocyclododecane (HBCD), 4-
nonylphenol (NP), 4-tert-octylphenol (OP), and pyridine (PhIP) at 0.0043, 0.0028, 0.0015, 0.0045, 
0.0048, 0.0044 nM, respectively) for two months, then the expression of DNA damage response 
markers were tested by Western blot using antibodies against phospho-Chk1 (Ser345), phospho-Chk2 
(Thr68), phospho-p53 (Thr18), and phosph-Histone H2A.X (Ser139). Markers were expressed to 
various levels in the cells exposed to these nanomolar concentrations of toxic agents for 2 months as 
compared to the untreated and DMSO control. Hydroxyurea (20 mM) was used as a positive control. 
2.3. Disruption of the Cell Cycle by Environmental Contaminants 
Flowcytometry showed that exposure to environmental contaminants has multiple effects on 
the cell cycle. However, this effect was variable according to the cell lines, environmental 
contaminant and duration of exposures, these effects are given in details in Figures S1 and S2. 
Figure 2. DNA damage response detected in the mammary epithelial cells HME1. Cells were
treated with toxic agents (bisphenol A (BPA), methoxychlor (MXC), hexabromocyclododecane (HBCD),
4-nonylphenol (NP), 4-tert-octylphenol (OP), and 2-amino-1-methyl-6-phenylimidazo [4–b] pyridine
(PhIP) at 0.0043, 0.0028, 0.0015, 0.0045, 0.0048, 0.0044 nM, respectively) for two months, then the
expression of DNA damage response markers were tested by Western blot using antibodies against
phospho-Chk1 (Ser345), phospho-Chk2 (Thr68), phospho-p53 (Thr18), and phosph-Histone H2A.X
(Ser139). Markers were expressed to various levels in the cells exposed to these nanomolar concentrations
of toxic agents for 2 months as compared to the untreated and DMSO control. Hydroxyurea (20 mM)
was used as a positive control.
2.3. isruption of the ell ycle by Environ ental onta inants
Flo cyto etry sho ed that exposure to environmental contaminants has multiple effects on the
cell cycle. However, this effect was variable according to the cell lines, environmental conta inant
and duration of exposures, these effects are given in details in Figures S1 and S2. Considering the
results from cells exposed to environmental contaminants alone (without treatment with doxorubicin),
we found that short exposure (24 h) to environmental contaminants induced mainly G2/M arrest in
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both MCF7 and HME1 with exception of OP in HME1 which increase in G1 peak. Other effects that
were also noted after 24 h such as that BPA, MXC, HBCD, and OP caused increases in S phase in MCF7.
After 48 h HME1was still showing the increase in G2/M but the MCF7 cell showed mainly increase in
the G1 or S phases consistent with the expectation that cancer cells may have developed mechanisms
to tolerate DNA damage. After 2 months exposure to these agents the MCF7 showed various effects
according to each agent with BPA, MXC, HBCD, and NP causing G1 and S phase increases while OP
caused G2/M and PhIP caused both S and G2/M phase increases; while HME1 showed an increase in S
phase (all agents), G1 (MXC, PhIP), and G2/M (BPA, HBCD, NP, and OP).
It was also noted that exposures to environmental contaminants caused subtle reduction of the
sub G1 peak (generally considered as a measure of apoptotic cells) that was induced by exposure to
doxorubicin alone; this finding could support the chemo-resistance effect of these agents.
2.4. Methylation Changes in Tumor Suppressor Genes and LINE1
We performed these experiments on the cells exposed for two months using a commercial panel
(MS-MLPA) which contains 24 well established tumor suppressor genes. Before any treatments, 15 of
the 24 tumor suppressor gene loci were unmethylated in the MCF7 breast cancer cells. All loci except
one (CDKN2B) were unmethylated in the untreated HME1 mammary epithelial cells. The vehicle
control (dimethyl sulfoxide, DMSO) induced some methylation events and hence we reported the
methylation in relation to this control. We observed that BPA induced hypermethylation of TIMP3,
CHFR, ESR1, and IGSF4 while HBCD induced TIMP3 tumor suppressor gene hypermethylation in
MCF7 breast cancer cell line. BPA additionally induced hypermethylation of CDH13 and GSTP1 in
HME1 mammary epithelial cells. There were some instances of reduction of methylation of already
methylated genes in MCF7 by BPA (CASP8, RASSF1, and GSTP1); therefore, we also tested LINE1
hypomethylation. LINE-1 methylation was slightly decreased in MCF7 treated with MXC, HBCD, NP,
OP, and PhIP but Dm values remained above 0.70. Details of methylation changes by environmental
contaminants are shown in Supplementary Table S1.
2.5. Environmental Contaminants and Collagen Invasion
In general, the results obtained by visual counting the number of invaded cells, matched the
results obtained by spectrophotometry. Almost all agents increased cellular invasiveness to various
degrees above the control (both untreated and vehicle; Figure 3).Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 6 of 17 
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Figure 3. Collagen invasion assay of mammary epithelial cell (HME1) cell line exposed to various
chemicals as compared to the base line invasion of control (vehicle-exposed) HME1 cell line. Cells were
treated with nanomolar concentrations (BPA, MXC, HBCD, NP, OP, and PhIP at 0.0043, 0.0028, 0.0015,
0.0045, 0.0048, and 0.0044 nM, respectively) for two months then cells were serum starved and tested
for their ability to invade through college-coated membrane using Boyden chambers. Invaded cells
were fixed, stained, and visualized under the microscope and then the dye was eluted and measured
using a plate reader. (A) Representative figures to show the differences in invasion potential as detected
by microscopic examination. (B) quantitative evaluation of cell invasion as measured by dye elution
and spectrophotometric reading at 560 nm. Mean ± SEM, * p < 0.05, n = 3.
2.6. Colony Formation in Soft Agar
Cell Transformation Detection Assay is an anchorage-independent growth assay in soft agar, which
is considered the most stringent assay for detecting malignant transformation of cells. This experiment
was performed on the 2-months-exposed cells. Some toxic agents showed increased colony formation
above the control level in MCF7 cell lines Figure S3, however, none of the HME1 stocks formed colonies
in soft agar under the test conditions.
2.7. Proteomic Analysis (Human Phospho Kinase Array)
In HME1 there was significant increase in 6 phosphoproteins: Epidermal growth factor receptor
(EGFR), cyclic AMP response eleme t binding protein (CREB), the signal tr nsducer and activator of
transcription 6 (STAT6), c-Jun, STAT3, a heat shock protein 60 (HSP60); d considerable increase
in some others such as heat shock protein 27 (HSP27), 5′-AMP-activated protein kinas catalytic
subunit alpha-1 (AMPKα1), Focal adhes on kinase (FAK), Glycogen synthase ki ase 3 alph /beta
(GSK3α/β), Tumor protein p53 (p53), Ribosomal protein S6 kinase beta-1 (S6K1), also known as
p70S6 kinase, ribosomal S6 kinase (RSK), Mitogen- and Stress-activated protein Kinases 1 and 2
(MSK1/2), p38 mitogen-activated protein kinases (p38α, MAPK14), and c-Jun N-terminal kinases
(JNK1/2) (Figure 4). All of these were induced by either all three or at least two of the tested toxic
agents (BPA, OP, HBCD). Interestingly, many of these activated phosphoproteins were not noticed in
MCA7 which showed much less induction of phospho kinases as compared to HME1.
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3. Discussion
In this work, we have generated data which might implicate exposure to low nanomolar
concentrations of six common environmental contaminants in breast cancer development.
Some of the tested agents interfered, to variable extent, with the cytotoxicity induced by
doxorubicin, suggesting that they could predispose to chemoresistance. These data are consistent with,
and adds emphasis on, the published work for BPA [19,20,33,34], the alkylphenols NP and OP [21],
and PhIP [30]. Our data are also consistent with the effect of HBCD [35] in breast cancer. Interestingly,
in some of the cited references above the described effect was induced by the smallest nanomolar
doses. Collectively, these data suggest that low dose of these agents might play a role in breast cancer
development through altered viability. These findings may also explain the increasing problem of
chemoresistance in breast cancer.
All toxic agents examined here showed potential to induce DNA damage as detected by
over-expression of some established markers (pH2AX, pCHK1, pCHK2, p-p53). BPA and OP induced
the highest number of DNA damage response markers suggestive of being the most extensive damage
inducing agents. The DNA damage was also accompanied by cell cycle disruption marked mainly by
arrest at G2/M phase which was bypassed after longer exposures in some instance. The survival of the
cells with damaged DNA can predispose to malignant transformation by creating a state of “genomic
instability” that accelerates acquisition of further oncogenic mutations [36].
Original mouse data described a pattern of epigenetic alteration dominated by hypomethylation
of estrogen target genes, such as Hoxa10 due to low dose exposure to BPA in utero [37]. Global genomic
hypomethylation was associated with BPA treatment also in other in vivo models such as zebrafish [38].
In the present work, we used a selected panel of 24 tumor suppressor genes. Our findings showed that
some agents induced tumor suppressor gene hypermethylation in this panel.
BPA induced hypermethylation of TIMP3, CHFR, ESR1, and IGSF4 while HBCD induced
TIMP3 tumor suppressor gene hypermethylation in MCF7 breast cancer cell line. BPA also induced
hypermethylation of CDH13, and GSTP1 in HME1 mammary epithelial cells. In addition, a few
loci that were heavily methylated in untreated MCF7 cells decreased in methylation after treatments.
Our pattern of hypermethylation and hypomethylation of selected genes resembles that reported
by Fernandez et al. (2012) based on MeDIP-on-chip experiments on BPA-exposed MCF-10F breast
epithelial cells [39]. Several of those tumor suppressor gene loci that we found hypermethylated
after exposure to toxic agents showed frequent hypermethylation in breast cancer cohorts studied
previously [40]. Our LINE-1 experiments did not reveal any significant hypomethylation when exposed
to toxic chemicals (some mild hypomethylation could be seen).
Interestingly, the accumulated DNA damage and epigenetic alterations, both of which represent
an essential base for cellular transformation and cancer development, were accompanied by features
of transformed phenotype such as increased cellular invasiveness consistent with some published
reports [15,30,31,41,42]. Recent literature suggested that BPA can disrupt mammary epithelial cells
organization into acinar structures [43], We also observed some increased cellular abilities to form
colonies in soft agar (anchorage independent growth) in MCF7 while this effect was not noted in HME1
at the test conditions. Cellular transformation might take prolonged periods and/or increasing doses,
or may be, exposure to combination of toxic agents or toxic agents and other condition such as obesity
or chronic inflammation. A recent study showed that combined exposures to two of the used agents
here (BPA and NP) produced larger effects than the effect of each component applied separately, which
could be the case in human life [44]. Even though our in vitro results are unable to explain how these
dynamics might work in vivo, it would be difficult to take the lack of colonies formation in HME1 as
an evidence against the oncogenicity of these agents in the presence of the accumulation of genetic
alterations and increased cellular invasiveness of these cells. Furthermore, the literature data supply
multiple evidence about the oncogenicity of BPA and many of these agents [15,30,42,45].
The phosphokinase array data uncovered many phosphoproteins and cellular pathways activated
during cellular response to these toxic agents particularly in the mammary epithelial cells (HME1).
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We can generally classify these phosphoproteins into three related groups which form intricate network
linking stress response to carcinogenesis. First and most important, many of the identified proteins
play a well-established or putative oncogenic role in different stages of mammary carcinogenesis.
Examples of these include EGFR, MSK1/2, CREB, FAK, GSK3α/β, S6K1/RSK, STAT2, STAT3, and STAT6.
MSK1/2 are required for EGF-induced, histone H3-Ser10 phosphorylation and promoter-associated
CREB phosphorylation and hence, early c-fos transcription in response to EGF [46]. The detection
of these three phosphorylated proteins (EGFR, MSK1/2, CREB) strongly supports a functional
consequences marked by EGF pathway transcriptional activity in response to toxic agents which could
be an important early step in breast cancer development [47,48]. FAK is a cytoplasmic tyrosine kinase
that plays critical role in integrin-mediated signal transductions. The activated FAK forms a complex
with Src kinases family, which initiates multiple downstream signaling. FAK plays a critical role in cell
migration and angiogenesis during cancer progression. EGF/IGF-I induced a co-localization of IGF-IR
and FAK, which was evident mostly at the cell membranes of MCF-7 breast cancer cell and caused cell
adhesion onto fibronectin, a marker of aggressive breast cancer [49]. The inhibitory phosphorylation of
GSK3β might enhance cell proliferation and migration via β-catenin/cyclin D1 signaling pathway in
breast cancer [50,51]. Both of p70S6 kinase and STAT3 could exert oncogenic potential in breast cancer
through a phosphatidylinositide 3-kinases (PI3K)/Protein kinase B (Akt/PKB)/p70S6 kinase signaling
pathway [52,53] while RSK is a family of Ser/Thr protein kinases (RSK1-4) that function downstream
of the Ras/mitogen-activated protein kinase (MAPK) signaling to trigger cell survival, growth, and
proliferation. Deregulated RSK activity has been associated with multiple cancer types including
breast cancer [54].
The second group of induced proteins includes AMPKα1, p38α/MAPK14, JNK1/2, c-Jun, MSK1/2,
CREB, HSP27, and HSP60 all of which could have a role in cellular stress and/or heat shock response.
However, more recently, many of these proteins turned out to play an important role in carcinogenesis
through an intricate network. The kinases MSK1 and MSK2 are linked to the epidermal growth
factor-pathway as discussed above while the p38/MSK1/CREB transcription was shown to have
oncogenic potential in some types of cancer [55]. In contrast to the earlier idea that HSPs are induced
as a consequence of oncogene activation in cancer, the available literature data suggest that HSP60
is an early biomarker during malignant transformation in many cancers such as those of the breast
and colon [56,57]. Researchers showed that bacterial and human HSP60 upregulate EGF, ERK, JNK,
and p38/epithelial MAP kinase pathway [58,59]. Mutant EGFR showed the ability to induce HSPs
such as HSP60 in lung carcinoma cells [60] suggesting a bidirectional positive feedback loop between
HSP60 and EGFR. HSP60 was also reported to interact with and activate β-catenin [61], and can act
as a ligand to Toll like receptor 4 (TLR4) that can activate the NF-κB pathway which is implicated
in tumor development through creating a state chronic inflammation that favor tumor growth [62].
Similarly, an accumulating body of evidence supports a role of HSP27 in carcinogenesis [63].
The third group includes some DNA damage response and DNA repair proteins (p53, Chk2,
and p27) which is consistent with and confirms our Western blot data described above.
Some of the pathways mentioned above such as STAT3, EGFR/ERK, HSPs, and DNA repair were
reported before in the context of exposure to environmental toxins particularly BPA [42], while the
rest of the kinases identified in the current work may be reported for the first time here. Additional
oncogenic pathways and mechanisms were reported in the literature. BPA was shown to reduce
retinoblastoma-associated protein and increase the Rac1 and CDC24 in normal mouse mammary
cultures [64]. BPA was also shown to promote angiogenesis through up regulation of X-linked inhibitor
of apoptosis via G protein-coupled estrogen receptor pathway [65].
Overall, the available data supply an important evidence to implicate very low doses of six
common environmental contaminants in inducing genotoxic/oncogenic alterations in mammary
epithelial cells. We elucidated significant pathways upregulated by environmental contaminants
which help understanding the mechanisms of action of these toxic agents. These data may explain the
remarkable increase in breast cancer incidence and chemoresistance worldwide.
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4. Materials and Methods
4.1. Cell Lines
MCF-7 cell line was isolated from malignant metastatic pleural effusion of a woman having
breast adenocarcinoma. It retains several ideal characteristics particular to the mammary epithelium
e.g., positivity for estrogen receptors (ER) and cytokeratin while non-reactive to desmin and vimentin
(mesenchymal markers). When grown in vitro, MCF7 can form domes and the epithelial like cells
that grow in monolayers with doubling time of 38 h. MCF7 had a wild type p53 gene sequence
(American Type Culture Collection, ATCC, Manassas, VA, USA). For this experiment, it was cultured
in phenol red free DMEM supplemented with, 1mM Sodium Pyruvate, 10% char coal stripped-fetal
bovine serum and 1x Penicillin and Streptomycin (Sigma-Aldrich, ST. Louis, MO, USA). hTERT-HME1
(HME1) was from Horizon Discovery (Cambridge, United Kingdom). It was derived from human
normal mammary epithelial cells immortalized by stable transfection of hTERT telomerase. It was
initially cultured as per the supplier conditions then maintained for the purpose of this experiment in
phenol red free DMEM/F12-ham supplemented with 10% char coal stripped-fetal bovine serum and 1x
Penicillin and Streptomycin (Sigma-Aldrich). All cells were maintained at 37 ◦C in a humidified 5%
CO2 incubator and were split before their confluency reached 90% according to supplier instructions.
4.2. Toxic Chemicals and Viability Assays
Environmental chemicals tested here were selected on the basis that they have a potential endocrine
disrupting effect and/or that they were previously implicated in cancer development. These included
BPA, NP, OP, MXC, HBCD, and PhIP. Chemicals were purchased from Sigma-Aldrich Corp. (BPA, NP,
OP, and HBCD), Supelco, Bellefonte, PA, USA (MXC); or MP Biomedicals LLC, Solon, OH, USA (PhIP).
Chemicals were dissolved in 100% dimethyl sulfoxide or as recommended and stored as stock solutions
at 4 ◦C. Initially we performed a pilot study to find out the effect of increasing doses of these agents on
viability using the standard MTT or Sulforhodamine B (SRB) method as described earlier [66]. For the
two-month exposures, cells were seeded in T25 tissue culture flasks without chemicals or DMSO over
night to settle and attach then chemicals or DMSO were added next morning. The DMSO concentration
did not exceed 1%. Media with fresh chemicals were replaced every 3 days. Cells were split before
they reached 90% confluency. All compounds tested concurrently. Stocks of exposed cells were frozen
down in liquid nitrogen after two months. Toxic agents-exposed cells were also tested for viability
after overnight exposure to doxorubicin. The IC50 concentration of Doxorubicin was determined as
before [66]. Cells were seeded in triplicates in each plate.
4.3. Detection of DNA Damage Response by Western Blot Analysis
Cell lysates were made from cultured cells washed twice with ice cold 1X PBS then the pellets
were lysed using pre-chilled Triton lysis buffer (25 mM Tris HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
1% Triton) to which (50 mM NaF, 1 mM Na3VO4, 1 mM PMSF and 2% Protease inhibitor) were added
freshly, incubated on ice for 5 min and centrifuged at speed of 14,000 rpm for 10 min at 4 ◦C to remove
the cell debris. Protein concentration was quantified using the BCA protein assay (Thermo Fisher
Scientific, Waltham, MA, USA). Approximately 30 µg of total protein were subjected to SDS-PAGE
(7.5% resolving gel, 4% stacking gel). The gel, with the separated proteins, was transferred to a PVDF
membrane (Bio-Rad Laboratories, Hercules, CA, USA) using a Trans-Blot® TurboTM Blotting system
(Bio-Rad) according to the standard transfer protocol. The membrane was blocked for 1 h at room
temperature using 5% non-fat dry milk (Sigma-Aldrich) in 1x TBST (TBS + 1% tween), followed by
incubation with the primary antibody overnight at 4 ◦C on a shaker. Phospho-antibodies were against
phospho-Chk1 (Ser345) clone 133D3, phospho-Chk2 (Thr68) clone C13C1, phospho-p53 (Thr18) and
phosph- Histone H2A.X (Ser139) clone 20E3 together with their matching antibodies against total
proteins, Beta-actin (clone 13E5). All antibodies were from Cell Signaling Technology (Danvers, MA,
USA) except phospho-p53 was from Santa Cruz Biotechnology (TX, USA). Primary antibodies were
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used at 1:1000 or at recommended dilutions by suppliers. Next, the membrane was washed with 1x
TBST 3 times for 10 min each. Then, it was incubated with horseradish peroxidase labeled secondary
antibody for 1 h at room temperature (anti-rabbit IgG HRP-linked antibody at dilution of 1:2000, Cell
Signaling). After washing with 1x TBST for 10 min 3 times, the HRP labeled membrane was incubated
with substrate (Pierce™ ECL Western Blotting Substrate, Waltham, MA, USA) for 1 min, exposed to
film (Kodak Cl-XPosure TM Film; catalog No: 34090; Company: Thermo Scientific), developed and
fixed. Pictures were then evaluated and scanned.
4.4. Analysis of DNA Content and Cell Cycle Progression
Cells were seeded at a density of 1× 106 cells/mL. After indicated timings, cells are harvested,
washed twice with PBS, and then re-suspended in 0.5 mL ice-cold PBS and later fixed with 4 mL ice
cold 70% ethanol for 48 h. Cells were then pelleted, washed twice with ice-cold PBS, re-suspended and
incubated at room temperature for 30 min in 0.2 mL staining buffer supplemented with 50 µg RNase
and propidium iodide (Sigma-Aldrich) at 50 µg/mL final concentration in the dark. Distribution of cell
cycle phases with different DNA contents Cells was analyzed by flowcytometry (BD FACS Aria™ III,
Becton-Dickinson, Franklin Lakes, NJ, USA). Analysis of cell cycle distribution and percentage of cells
in G1, S, and G2/M phases of the cell cycle were determined using the cell cycle platform of the FlowJo
software v10.6.2 with the Watson pragmatic model (Tree Star, Ashland OR, USA).
4.5. Methylation Specific Multiplex-Ligation Dependent Probe Amplification (MS-MLPA)
We used SALSA MS-MLPA Tumor suppressor Kit ME001-C1 (MRC, Amsterdam, Holland) to
study promoter methylation of 24 tumor suppressor genes (TSGs) in tumor and normal samples
according to manufacturer’s instructions (http://www.mrc-holland.com). This kit contains 26 probes for
24 TSGs, which were described in detail in our previous publication [67]. For each reaction, 200–800 ng
of DNA was used. Each MS-MLPA reaction generates two aliquots, one undigested and one digested
and these can be used for copy number and methylation detection respectively. MS-MLPA utilizes
methylation sensitive enzyme HhaI and probes have a recognition sequence against this enzyme.
Only templates with methylated HhaI sites, resistant to HhaI cleavage, generate a signal after probe
ligation. Amplification products were separated by capillary electrophoresis and analyzed with ABI
Prism GeneMapper 4.0 (Applied Biosystems, Waltham, MA, USA). In every assay, normal DNA
derived from healthy individuals’ lymphocytes was included as a control for the lack of methylation
and tumor cell line (RKO) was included as a reference for frequent methylation. Methylation dosage
ratios were calculated as described in our previous study [67], in which a value of 0.15 (corresponding
to 15% of methylated DNA) was used as cut-off level for methylation. This analysis was performed on
the two-month exposed cells to the low concentration of all agents.
For LINE-1 hypomethylation analysis (MS-MLPA) we followed the protocol described in our
previous publication [68]. The custom designed probes target three different areas inside the
LINE-1 promoter sequence (L1-1m, L1-2m, L1-3m). These sites were specified in the same reference.
Whole genome amplified (WGA) DNA was used as a technical control for low LINE-1 methylation.
WGA controls showed decreased LINE-1 methylation below the threshold of 0.70.
4.6. Invasion Assay
For the invasion assay, we used QCMTM High Sensitivity Non-cross-linked Collagen Invasion
Assay kits (Merck group, Darmstadt, Germany) and followed the supplied manufacturer protocol.
Briefly, the assay was performed using a modified chamber with filter inserts (pore size 8 µm) coated
with matrigel in 24-well dishes. Approximately 0.5 million cells were prepared in the corresponding
serum-free media. Two hundred and fifty microliters of the cell suspension were added into the inserts
(top chamber) and 500 µL of 15% FBS-containing media were added to the bottom chamber. After 48-h
incubation, cells remaining in the top chamber were removed and 400 µL of cell stain were applied
to the invasion chamber insert for 15 min. After several washes with water, the inserts were dried,
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viewed under the microscope, photographed, and the numbers of invaded cells were counted/5 fields
each 200×magnification. Inserts were then transferred into 200 µL of extraction buffer and allowed
to incubate for 15 min at room temperature. The dye mixture was then assessed by a plate reader at
a wavelength of 630 nm.
4.7. Colony Formation in Soft Agar
Colony formation was analyzed using commercial kits (Cell Transformation Detection Assay;
Merck group, Darmstadt, Germany). Cells pre-treated with carcinogens or control cells were cultured
with appropriate controls in soft agar medium for 21–28 d. HeLa was used as a reference/positive
control while the DMSO exposed cells were used as negative control. The, formed colonies were
analyzed and counted morphologically using cell stain solution. This analysis was performed on the
two-month exposed cells to the low concentration of all agents.
4.8. Proteome Profile/Human Phospho-Kinase Array
For molecular pathway analysis we used a “human phospho-kinase array” ready-made kit which
analyzes alterations of kinase signaling in response to exposure to selected three agents (BPA, OP,
HBCD) which showed the most significant response at most of the previous tests. The array analyses
43 kinase phosphorylation sites and 2 related total proteins with carefully selected specific capture
antibodies. The experimental technique and analyses were according to manufacturer’s booklet
which also contains a list of the targets and phosphorylation sites (Proteome Profiler; R&D Systems,
Minneapolis, MN, USA). This analysis was performed on the two-month exposed HME1 cells to low
concentration of BPA, OP, HBCD and vehicle (DMSO). selected results were confirmed by Western blot.
4.9. Data Analysis:
We used analysis of variance (one-way ANOVA) for mean comparisons. When the ANOVA
test showed statistical differences, the Tukey post hoc test was used to discriminate between groups.
t-Test was used to calculate significance of 2 independent means. p value of < 0.05 was considered to
determine statistical significance and 0.05 < p < 0.10 indicated a tendency.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/10/
3735/s1.
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